Breast cancer cells express four types of 5-HT receptors, and their binding to 5-HT induces PTHrP through RUNX2, inhibits osteoblast maturation and activates osteoclasts through the RANKL pathway [207]. The gene discussed is TNFSF11; the disease is breast cancer.